International nonproprietary names for biological and biotechnological drugs

by V. V. Dudchenko, P. I. Popov, N. D. Bunyatyan, A. N. Yavorsky, V. A. Merkulov
Published 2018-02-01

RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS

by R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov
Published 2018-02-01

The landmarks of control and licensing system development for medicinal products in Russia (25 years since the establishment of the first state institution for expert evaluation of...

by V. K. Lepakhin, Yu. V. Olefir, V. A. Merkulov, N. D. Bunyatyan, B. K. Romanov, A. N. Yavorsky, E. M. Rychihina
Published 2018-02-01

PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROSCLEROSIS

by A. L. Khokhlov, A. N. Yavorsky, N. O. Pozdnyakov, J. V. Rybachkova, E. S. Emelianov, A. A. Khokhlov, A. E. Miroshnikov, S. O. Pozdnyakov
Published 2018-02-01

On the need to improve the legislation on laboratory animals

by A. A. Mokhov, A. N. Murashev, M. S. Krasilshchikova, O. N. Khokhlova, S. G. Semushina, E. A. Rasskazova, D. I. Rzhevskiy, V. S. Popov, A. N. Yavorsky
Published 2018-02-01